FDA Watch report · October 2026
What FDA cited at consumer products plants this year.
Twelve months of FDA inspection findings and recalls across OTC and personal care, food and medical devices, read by an operator. Six findings, and what plant leaders can do about each.
Key findings
Six things the data says.
Microbes are the top reason OTC and personal care products get recalled.
19 of 54 recall events (35%) in the last 12 months cited microbial contamination, more than twice the next cause.
The most-cited drug-plant problem is procedures that aren’t written down or followed.
21 CFR 211.22(d) drew 107 Form 483 observations, followed by weak investigations of failures under 211.192 (96).
Operations owns a large share of the findings.
Equipment and maintenance was the most-cited theme in drug and cosmetic inspections (213 observations), ahead of quality unit oversight (135). Validation (200) and records (167) were close behind.
Water failures are rare, but serious when they happen.
Seven recalls in three years named water-borne organisms such as Pseudomonas, Burkholderia and Achromobacter. Investigators also wrote 14 observations on objectionable-microorganism controls in non-sterile drugs (211.113(a)).
In food, supplier control is the biggest inspection theme, and allergens drive recalls.
Supplier quality led with 1,634 observations; developing a Foreign Supplier Verification Program was the single most-cited requirement (326). Undeclared allergens caused 191 of 531 recall events (36%).
For devices, design and components drive recalls, and CAPA drives findings.
Design, software or component issues were behind 356 of 974 recall events (37%). CAPA and investigations was the top inspection theme (376 observations).
OTC & personal care
Where recalls and findings come from.
54 recall events (3 Class I) and 333 drug and cosmetic inspections that ended with a Form 483, totaling 1,299 observations.
Recall events by root cause
OTC drugs and cosmetics, last 12 months
| Category | Count |
|---|---|
| Microbial contamination | 19 |
| Potency, stability or spec failure | 9 |
| cGMP deviations | 8 |
| Labeling or packaging | 6 |
| Chemical or impurity | 3 |
| Foreign material | 2 |
| Design or component | 1 |
| Other | 6 |
Form 483 observations by theme
Drug (incl. OTC) and cosmetic inspections, top six themes
| Category | Count |
|---|---|
| Equipment & maintenance | 213 |
| Lab controls & stability | 204 |
| Validation & process control | 200 |
| Records & data integrity | 167 |
| CAPA & investigations | 151 |
| Quality unit oversight | 135 |
Most-cited regulations
Drug (incl. OTC) and cosmetic inspections, last 12 months
| Regulation | What it covers | Observations |
|---|---|---|
21 CFR 211.22(d) | Quality unit procedures not in writing or not followed | 107 |
21 CFR 211.192 | Investigations of discrepancies and failures | 96 |
21 CFR 211.160(b) | Scientifically sound laboratory controls | 68 |
21 CFR 211.100(a) | Written production and process control procedures | 61 |
21 CFR 211.67(a) | Equipment cleaning, sanitizing and maintenance | 49 |
21 CFR 211.68(b) | Computer controls over master formula and records | 41 |
21 CFR 211.67(b) | Equipment cleaning procedures established and followed | 39 |
Most of these are execution findings, not science findings. When procedures don’t match the floor and investigations stop at “operator error,” the same problems come back. Start by walking your top five procedures with the people who run them, and audit your last ten closed investigations for real root cause.
USP water
The first ingredient, and the first risk.
Water is in most consumer products, and organisms such as Burkholderia and Pseudomonas grow in poorly controlled systems.
Trend your water micro data weekly, not just at alert and action limits, and make sure someone owns sanitization frequency, dead legs and sampling-point coverage. A water excursion investigated quickly is a deviation; one found by FDA is a finding.
Food & medical devices
Different rules, similar lessons.
Food: 531 recall events (207 Class I) and 2,306 inspections with a 483. Devices: 974 recall events (113 Class I) and 517 inspections with a 483.
Food recall events by root cause
Last 12 months
| Category | Count |
|---|---|
| Undeclared allergen | 191 |
| Microbial contamination | 161 |
| Foreign material | 65 |
| Labeling or packaging | 27 |
| cGMP deviations | 8 |
| Chemical or impurity | 7 |
| Other | 72 |
Device recall events by root cause
Last 12 months
| Category | Count |
|---|---|
| Design, software or component | 356 |
| Labeling or packaging | 177 |
| Microbial contamination | 100 |
| Potency or spec failure | 40 |
| Foreign material | 37 |
| Other | 264 |
In food, the weak link is often upstream: supplier verification and label control at changeover. In devices, it’s the loop from complaint to CAPA to design change. In both, the fix is the same habit: close the loop, and check that the fix worked.
Method & sources
Recall data comes from openFDA enforcement reports for drugs, food and devices (12 months; water-borne organism recalls over 36 months). Inspection observations and warning letters come from the FDA Data Dashboard, covering inspections with a Form 483 in the last 12 months. Drug figures combine OTC and prescription drug inspections; cosmetics inspections are included with OTC and personal care. Root causes and themes are assigned by Claraxis using the recall reason and the cited regulation, so totals are approximate.
Numbers reflect FDA data as published on October 2, 2026, and will change as FDA updates its records. This report is for general information and isn’t regulatory or legal advice. The live FDA Watch updates every six hours.
The FDA Watch brief
Get the monthly FDA Watch brief
Once a month: what FDA investigators cited at consumer products plants, the recalls worth knowing about, and one operator’s take on what to do about it. Five minutes to read. No spam, unsubscribe anytime.
From findings to fixes
Want this read for your plant?
Kobe can walk your operation against what FDA is citing and rank what to fix first.